Sign In
Buy VIR
$8.66
-0.240 (-2.70%)
At Close: Jul 31, 2026
VIR Stock Price: Why It Fell Over 21%
02:54pm, Saturday, 02'nd Oct 2021
The stock price of Vir Biotechnology Inc (NASDAQ: VIR) fell by over 21% in the previous trading session. This is why it happened.
Vir Biotechnology to Participate in the Guggenheim 2nd Annual Vaccine & Infectious Disease Day Conference
04:05pm, Thursday, 30'th Sep 2021
SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., chief medical officer, is scheduled to present at the Guggenheim 2n
Why Vir Biotechnology Stock Is Sinking This Week
06:02am, Friday, 24'th Sep 2021
Shares fell after an analyst's downgrade.
Director Of Vir Biotechnology Sold $796.30 Thousand In Stock
12:45pm, Wednesday, 22'nd Sep 2021
Vicki Sato, Director at Vir Biotechnology (NASDAQ:VIR), made a large insider sell on September 17, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange C
Week 37 MDA Breakout Stocks - September 2021: Short-Term Picks To Give You An Edge
04:30am, Monday, 13'th Sep 2021
Two new Breakout Stocks for Week 37 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. Following the Momentum Gauges, the portfolio is u
Vir Biotechnology to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
04:05pm, Wednesday, 08'th Sep 2021
SAN FRANCISCO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that George Scangos, Ph.D., chief executive officer, will participate in a virtual fireside chat
Vir Biotechnology to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
04:05pm, Tuesday, 07'th Sep 2021
SAN FRANCISCO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Howard Horn, chief financial officer, is scheduled to present at the H.C. Wainwright 23rd A
Now May Be the Big Moment for These 2 COVID Stocks
06:00am, Thursday, 02'nd Sep 2021
Their products are seeing a surge in demand.
Antibody drugs take off in new Covid surge
03:23pm, Tuesday, 31'st Aug 2021
Meg Tirrell joins The Exchange with more information about Covid antibody treatments and the increasing demand for these drugs in places where the delta variant is surging. For access to live and excl
Coronavirus antibody drugs take off
10:49am, Monday, 30'th Aug 2021
CNBC's Meg Tirrell reports on the surge in Covid antibody drug orders.
Vir Biotech-GSK's COVID-19 Treatment Wins Provisional Approval In Australia
12:05pm, Monday, 23'rd Aug 2021
The Australian Therapeutic Goods Administration has granted provisional marketing authorization for Vir Biotechnology Inc's (NASDAQ: VIR) for sotrovimab, a monoclonal antibody for COVID-19. The ap
Vir Biotechnology Announces First Marketing Authorization for its First Commercial Product, Sotrovimab, Granted in Australia
08:30am, Monday, 23'rd Aug 2021
– First monoclonal antibody authorized in Australia – – First monoclonal antibody authorized in Australia –
VIR Stock Price Increases Over 10% Pre-Market: Why It Happened
06:30am, Friday, 06'th Aug 2021
The stock price of Vir Biotechnology, Inc. (Nasdaq: VIR) increased by over 10% pre-market. This is why it happened.
Vir Biotechnology, Inc. (VIR) Q2 Earnings and Revenues Beat Estimates
07:01pm, Thursday, 05'th Aug 2021
Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of 167.65% and 205.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock
Europe buys 220,000 doses of Vir, GSK's experimental COVID-19 treatment
08:51am, Wednesday, 28'th Jul 2021
Shares of Vir Biotechnology Inc. gained 1.9% in premarket trading on Wednesday after the company and GlaxoSmithKline said the European Commission purchased 220,00 doses of their investigational COVID-
